annual CFO:
-$83.03M+$34.47M(+29.33%)Summary
- As of today (July 1, 2025), TARS annual cash flow from operations is -$83.03 million, with the most recent change of +$34.47 million (+29.33%) on December 31, 2024.
- During the last 3 years, TARS annual CFO has fallen by -$86.78 million (-2315.23%).
- TARS annual CFO is now -2315.23% below its all-time high of $3.75 million, reached on December 31, 2021.
Performance
TARS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$20.65M+$1.53M(+6.90%)Summary
- As of today (July 1, 2025), TARS quarterly cash flow from operations is -$20.65 million, with the most recent change of +$1.53 million (+6.90%) on March 31, 2025.
- Over the past year, TARS quarterly CFO has increased by +$17.14 million (+45.35%).
- TARS quarterly CFO is now -200.49% below its all-time high of $20.55 million, reached on June 30, 2021.
Performance
TARS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$65.89M+$17.14M(+20.64%)Summary
- As of today (July 1, 2025), TARS TTM cash flow from operations is -$65.89 million, with the most recent change of +$17.14 million (+20.64%) on March 31, 2025.
- Over the past year, TARS TTM CFO has increased by +$67.42 million (+50.58%).
- TARS TTM CFO is now -1225.15% below its all-time high of $5.86 million, reached on September 30, 2021.
Performance
TARS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TARS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.3% | +45.4% | +50.6% |
| 3 y3 years | -2315.2% | -35.1% | -10000.0% |
| 5 y5 years | -2160.5% | -934.6% | -1347.2% |
TARS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2315.2% | +29.3% | -384.9% | +47.5% | -168.3% | +50.6% |
| 5 y | 5-year | -2315.2% | +29.3% | -200.5% | +47.5% | -1225.2% | +50.6% |
| alltime | all time | -2315.2% | +29.3% | -200.5% | +47.5% | -1225.2% | +50.6% |
TARS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$20.65M(-6.9%) | -$65.89M(-20.6%) |
| Dec 2024 | -$83.03M(-29.3%) | -$22.18M(+156.4%) | -$83.03M(-17.1%) |
| Sep 2024 | - | -$8.65M(-39.9%) | -$100.18M(-19.1%) |
| Jun 2024 | - | -$14.40M(-61.9%) | -$123.89M(-7.1%) |
| Mar 2024 | - | -$37.79M(-3.9%) | -$133.31M(+13.5%) |
| Dec 2023 | -$117.49M(+139.6%) | -$39.34M(+21.5%) | -$117.49M(+32.0%) |
| Sep 2023 | - | -$32.36M(+35.8%) | -$89.03M(+18.3%) |
| Jun 2023 | - | -$23.83M(+8.4%) | -$75.28M(+35.1%) |
| Mar 2023 | - | -$21.97M(+102.0%) | -$55.71M(+13.6%) |
| Dec 2022 | -$49.03M | -$10.87M(-41.6%) | -$49.03M(-2.5%) |
| Sep 2022 | - | -$18.61M(+337.0%) | -$50.28M(+104.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$4.26M(-72.1%) | -$24.55M(-9691.4%) |
| Mar 2022 | - | -$15.29M(+26.1%) | $256.00K(-93.2%) |
| Dec 2021 | $3.75M(-117.7%) | -$12.12M(-270.4%) | $3.75M(-36.0%) |
| Sep 2021 | - | $7.11M(-65.4%) | $5.86M(-174.8%) |
| Jun 2021 | - | $20.55M(-274.2%) | -$7.83M(-74.7%) |
| Mar 2021 | - | -$11.79M(+17.8%) | -$30.94M(+46.4%) |
| Dec 2020 | -$21.14M(+475.5%) | -$10.01M(+52.4%) | -$21.14M(+90.0%) |
| Sep 2020 | - | -$6.57M(+157.0%) | -$11.13M(+144.3%) |
| Jun 2020 | - | -$2.56M(+28.1%) | -$4.55M(+128.1%) |
| Mar 2020 | - | -$2.00M | -$2.00M |
| Dec 2019 | -$3.67M(+210.5%) | - | - |
| Dec 2018 | -$1.18M | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual CFO year-on-year change?
- What is Tarsus Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly CFO year-on-year change?
- What is Tarsus Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM CFO year-on-year change?
What is Tarsus Pharmaceuticals annual cash flow from operations?
The current annual CFO of TARS is -$83.03M
What is the all time high annual CFO for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual cash flow from operations is $3.75M
What is Tarsus Pharmaceuticals annual CFO year-on-year change?
Over the past year, TARS annual cash flow from operations has changed by +$34.47M (+29.33%)
What is Tarsus Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of TARS is -$20.65M
What is the all time high quarterly CFO for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly cash flow from operations is $20.55M
What is Tarsus Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, TARS quarterly cash flow from operations has changed by +$17.14M (+45.35%)
What is Tarsus Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of TARS is -$65.89M
What is the all time high TTM CFO for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM cash flow from operations is $5.86M
What is Tarsus Pharmaceuticals TTM CFO year-on-year change?
Over the past year, TARS TTM cash flow from operations has changed by +$67.42M (+50.58%)